A randomized phase II study of docetaxel with or without vandetanib in recurrent or metastatic squamous cell carcinoma of head and neck (SCCHN)

Sewanti Limaye, Sarah Riley, Sihai Zhao, Anne O'Neill, Marshall Posner, Douglas Adkins, Zachary Jaffa, John Clark, Robert Haddad

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'A randomized phase II study of docetaxel with or without vandetanib in recurrent or metastatic squamous cell carcinoma of head and neck (SCCHN)'. Together they form a unique fingerprint.

Medicine & Life Sciences